Sep. 8 at 7:48 PM
$ARCT As a long term shareholder of ARCT, and having listened to almost every conference given over the past several years, I can say that today's conference is one of the best I've ever listened to. While the information provided in today's conference is already pretty well known by those of us who are well versed shareholders, the increased comfort and conviction in which Joe speaks is very evident to those who have heard him speak in the past. He cleary knows what he knows. Without any doubt there is increasing interest in Arcturus Therapeutics from pharmaceutical companies who are looking for opportunities in the MRNA space, and it's increasingly looking like Arcturus Therapeutics may be becoming the bell of the ball.
